SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-033652
Filing Date
2023-07-20
Accepted
2023-07-20 14:55:48
Documents
14
Period of Report
2023-07-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20230720.htm   iXBRL 8-K 59971
2 EX-99.1 rkda-ex99_1.htm EX-99.1 18081
3 GRAPHIC img192114479_0.jpg GRAPHIC 3553
  Complete submission text file 0000950170-23-033652.txt   204378

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20230720_lab.xml EX-101.LAB 13360
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20230720_pre.xml EX-101.PRE 9839
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20230720.xsd EX-101.SCH 2463
8 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20230720_htm.xml XML 4671
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 231099421
SIC: 0100 Agricultural Production-Crops